Cargando…
How do we evaluate outcome in an integrative oncology program?
Integrative oncology focuses on the roles of complementary therapies to increase the effectiveness of conventional cancer treatment programs by improving defined outcomes such as symptom control, quality of life, rehabilitation, and prevention of recurrence. Implementation of integrative oncology pr...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Multimed Inc.
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2528566/ https://www.ncbi.nlm.nih.gov/pubmed/18769584 |
_version_ | 1782158882645213184 |
---|---|
author | Sagar, S.M. |
author_facet | Sagar, S.M. |
author_sort | Sagar, S.M. |
collection | PubMed |
description | Integrative oncology focuses on the roles of complementary therapies to increase the effectiveness of conventional cancer treatment programs by improving defined outcomes such as symptom control, quality of life, rehabilitation, and prevention of recurrence. Implementation of integrative oncology programs should be based on the best evidence and must continually be evaluated to ensure quality, optimization of techniques, collection of new data, and cost-effectiveness. Useful domains that can be evaluated include symptom control, adherence to treatment protocols, quality of life, individual outcomes, prevention, rehabilitation, potential advantages of a whole-systems health approach, and economics of health services. |
format | Text |
id | pubmed-2528566 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | Multimed Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-25285662008-09-03 How do we evaluate outcome in an integrative oncology program? Sagar, S.M. Curr Oncol Integrative Oncology Integrative oncology focuses on the roles of complementary therapies to increase the effectiveness of conventional cancer treatment programs by improving defined outcomes such as symptom control, quality of life, rehabilitation, and prevention of recurrence. Implementation of integrative oncology programs should be based on the best evidence and must continually be evaluated to ensure quality, optimization of techniques, collection of new data, and cost-effectiveness. Useful domains that can be evaluated include symptom control, adherence to treatment protocols, quality of life, individual outcomes, prevention, rehabilitation, potential advantages of a whole-systems health approach, and economics of health services. Multimed Inc. 2008-08 /pmc/articles/PMC2528566/ /pubmed/18769584 Text en 2008 Multimed Inc. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Integrative Oncology Sagar, S.M. How do we evaluate outcome in an integrative oncology program? |
title | How do we evaluate outcome in an integrative oncology program? |
title_full | How do we evaluate outcome in an integrative oncology program? |
title_fullStr | How do we evaluate outcome in an integrative oncology program? |
title_full_unstemmed | How do we evaluate outcome in an integrative oncology program? |
title_short | How do we evaluate outcome in an integrative oncology program? |
title_sort | how do we evaluate outcome in an integrative oncology program? |
topic | Integrative Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2528566/ https://www.ncbi.nlm.nih.gov/pubmed/18769584 |
work_keys_str_mv | AT sagarsm howdoweevaluateoutcomeinanintegrativeoncologyprogram |